Greg Baker, CEO of AffirmedRx, shared with MHE editors how the company is addressing ongoing challenges in the pharmacy ...

Prescription of Neurontin (gabapentin) and other gabapentinoids has increased partly because they are viewed as a safer ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

The menopause market is projected to increase at a CAGR of 5.10% between 2025 – 2033, with North America making up 4.9% ...

Attruby (acoramidis) is a small molecule approved to treat adults with transthyretin amyloid cardiomyopathy. It will have a ...

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

Seemal Desai, M.D., FAAD, discusses how treatment safety and effectiveness must be carefully evaluated through monitoring ...

Marty Makary, M.D., M.P.H., as FDA administrator may be the least controversial of Trump's picks for the top healthcare jobs so far.

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

During the COVID-19 pandemic, healthcare workers faced several mental health challenges, experiencing repeated exposure to ...

After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked ...

An intervention program that coaches patients in stress management and goal setting, along with a digital app, helped ...